Company / SG&A Expense
Nutex Health, Inc. SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$51.7M
FY2025
5-year range
$5.5M / $51.7M
FY2021-FY2025
Trend
+23.2%
vs FY2024
Sector context
#283 of 302
Industrials
What the data says
Among 302 Industrials companies, Nutex Health, Inc. is in the top 6% for sg&a expense. SG&A Expense has increased for 7 consecutive years, from $945,607 in FY2018 to $52M in FY2025.
Based on SEC 10-K filings.
$52M in FY2025 with a 5-year CAGR of +63.4%.
Increased from $33M to $52M over the past 2 years.
Industrials sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +37.6%
- 5-Year CAGR
- +63.4%
- 10-Year CAGR
- -
Sector benchmark
Top 6% in IndustrialsTop 6% of 302This company $51.7M Sector average $871.1M
▼
-94.1% below sector average
Key checks
Key Insights
- Nutex Health, Inc.'s sg&a expense has grown for 7 consecutive years.
- 5-year CAGR of +63.4%, indicating consistent growth.
- In FY2025, sg&a expense increased 23.2% year-over-year.
- Ranks #283 out of 302 companies in the Industrials sector.
Company context
Key Data Points
- Strong profit margin: 40.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $51.7M | +23.2% |
| FY2024 | $41.9M | +26.2% |
| FY2023 | $33.2M | +67.7% |
| FY2022 | $19.8M | +262.7% |
| FY2021 | $5.5M | +23.2% |
| FY2020 | $4.4M | +20.9% |
| FY2019 | $3.7M | +287.8% |
| FY2018 | $945.6K | -47.9% |
| FY2017 | $1.8M | +304.3% |
| FY2016 | $448.6K | -15.8% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026